Anat Lebow, MD Dermatology is categorized under Physicians/Surgeons-Podiatrist Reference in New York City, NY .
Anat Lebow, MD Dermatology was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Physicians/Surgeons-Podiatrist Reference business, which does work in the B2C market, and is classified as a Physicians/Surgeons-Podiatrist Reference, under code number by the NAICS.
If you are seeking more information, feel free to contact Abat Lebow at the company’s single location by writing to 635 Madison Avenue
3rd Floor, New York City, New York NY 10023 or by phoning (212) 753-1040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Anat Lebow, MD Dermatology |
| Contact Person: | Abat Lebow |
| Address: | 635 Madison Avenue 3rd Floor, New York City, New York 10023 |
| Phone Number: | (212) 753-1040 |
| Website Address: | anatlebowmd.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians/Surgeons-Podiatrist Reference |
| Share This Business: |
Anat Lebow, MD Dermatology was started in 0 to provide professional Physicians/Surgeons-Podiatrist Reference under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Abat Lebow for inquiries that concern Anat Lebow, MD Dermatology by calling the company number (212) 753-1040, as your correspondence is most welcome.
Additionally, the physical location of the single location of Anat Lebow, MD Dermatology can be found at the coordinates 40.7639,-73.97118 as well as the street address 635 Madison Avenue
3rd Floor in New York City, New York 10023.
For its online presence, you may visit Anat Lebow, MD Dermatology’s website at anatlebowmd.com and engage with its social media outlets through on Twitter and on Facebook.